USFDA concludes inspection of Shilpa Medicare with four observations
The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India
The plant is expected to start commercial operations from Q4FY24
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Glenmark Pharmaceuticals won Innovation of the Year award
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
This facility will design & develop instruments, perform product reliability performance testing and verification
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
The minister was speaking at the 7th International conference on Pharma and Medical Devices sector; chairs two roundtable conferences with the CEOs
The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation
Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'
The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)
Subscribe To Our Newsletter & Stay Updated